124 related articles for article (PubMed ID: 34326151)
21. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
[TBL] [Abstract][Full Text] [Related]
22. Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group.
Sugarbaker DJ; Herndon J; Kohman LJ; Krasna MJ; Green MR
J Thorac Cardiovasc Surg; 1995 Mar; 109(3):473-83; discussion 483-5. PubMed ID: 7877308
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.
Ginsberg RJ; Rubinstein LV
Ann Thorac Surg; 1995 Sep; 60(3):615-22; discussion 622-3. PubMed ID: 7677489
[TBL] [Abstract][Full Text] [Related]
24. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
25. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary metastasectomy for suspected pancreaticobiliary cancer.
Robinson LA; Tanvetyanon T; Springett G; Fontaine J; Toloza E; Hodul P; Pimiento JM; Malafa M
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):75-82. PubMed ID: 27050555
[TBL] [Abstract][Full Text] [Related]
27. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE
Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Schilder RJ; Goldberg M; Millenson MM; Movsas B; Rogatko A; Rogers B; Langer CJ
Lung Cancer; 2000 Jan; 27(1):37-45. PubMed ID: 10672782
[TBL] [Abstract][Full Text] [Related]
29. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).
Colice GL; Shafazand S; Griffin JP; Keenan R; Bolliger CT;
Chest; 2007 Sep; 132(3 Suppl):161S-77S. PubMed ID: 17873167
[TBL] [Abstract][Full Text] [Related]
30. [Sublobar Resection for Patients with a Metachronous Second Primary Lung Cancer Following Curative Resection of a Primary Lung Cancer].
Azuma Y; Koezuka S; Iyoda A
Kyobu Geka; 2019 Jan; 72(1):57-61. PubMed ID: 30765630
[TBL] [Abstract][Full Text] [Related]
31. Surgery for early stage non-small cell lung cancer.
Manser R; Wright G; Hart D; Byrnes G; Campbell DA
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004699. PubMed ID: 15674959
[TBL] [Abstract][Full Text] [Related]
32. Performance of wider parenchymal lung resection than preoperatively planned in patients with low preoperative lung function performance undergoing video-assisted thoracic surgery major lung resection.
Kouritas VK; Kefaloyannis E; Milton R; Chaudhuri N; Papagiannopoulos K; Brunelli A
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):889-894. PubMed ID: 27516423
[TBL] [Abstract][Full Text] [Related]
33. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.
Simunovic M; Rempel E; Thériault ME; Coates A; Whelan T; Holowaty E; Langer B; Levine M
Can J Surg; 2006 Aug; 49(4):251-8. PubMed ID: 16948883
[TBL] [Abstract][Full Text] [Related]
34. [Surgical Treatment and Outcomes for Synchronous Multiple Lung Cancer].
Watanabe T; Tanahashi M; Suzuki E; Yoshii N; Chiba K; Tsuchida H; Yobita S; Iguchi K; Uchiyama S
Kyobu Geka; 2021 Jan; 74(1):9-15. PubMed ID: 33550313
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
Albain KS; Swann RS; Rusch VW; Turrisi AT; Shepherd FA; Smith C; Chen Y; Livingston RB; Feins RH; Gandara DR; Fry WA; Darling G; Johnson DH; Green MR; Miller RC; Ley J; Sause WT; Cox JD
Lancet; 2009 Aug; 374(9687):379-86. PubMed ID: 19632716
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
[TBL] [Abstract][Full Text] [Related]
37. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
Phillips I; Sandhu S; Lüchtenborg M; Harden S
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
[TBL] [Abstract][Full Text] [Related]
39. Survival outcome in New Zealand after resection of colorectal cancer lung metastases.
Goonerante D; Gray C; Lim M; Dixon L; Dobbs B; Wakeman C; Frizelle F;
ANZ J Surg; 2013 Dec; 83(12):959-62. PubMed ID: 23186081
[TBL] [Abstract][Full Text] [Related]
40. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]